BrightInsight Secures $13M Funding Round
Summary
BrightInsight announced a $13 million investment round from existing and new investors, including Eclipse, General Catalyst, Insight Partners, Mayo Clinic, and New Leaf Venture Partners. The company will use the capital to accelerate development of its AI-enabled medication persistence and adherence solutions and to rapidly scale high-impact programs globally. BrightInsight positions its cloud-based platform as the foundation for patient companion apps, digital-first patient support programs (PSP), and Software as a Medical Device (SaMD) solutions for life sciences companies. The funding will also support wider rollout of the Patient App developed in collaboration with Sanofi and Regeneron across a broader range of diseases and therapies.
Funding
Amount
$13.0M
Total raised
Date
January 20, 2026
Announcement date
Investors
Insight Partners, New Leaf Venture Partners, Aventis, Regeneron Pharmaceuticals, Mayo Medical Ventures, General Catalyst
Lead investors
Company
brightinsight.com
Funded company
Classifications
industries
HealthTech
applications
Data Management
AskAI Classifications
Labels
Healthcare Software
Digital Health SaaS
Medical Device Software
Linked Companies
BrightInsight
$10M to $25M